{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:54:43Z","timestamp":1780552483587,"version":"3.54.1"},"reference-count":44,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T00:00:00Z","timestamp":1693180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aims<\/jats:title><jats:p>Sweet's syndrome is an acute febrile neutrophilic dermatosis first described in 1964 by Robert Douglas Sweet. The pathophysiological mechanism is not fully established; however, several cases of Sweet's syndrome have been reported following drug administration.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>To investigate the existence of pharmacovigilance signals between drugs and the occurrence of Sweet's syndrome, we performed a case\/non\u2010case study on reports of \u2018acute febrile neutrophilic dermatosis\u2019 registered in the French pharmacovigilance database. Reporting odds ratio (ROR) with its 95% confidence interval were calculated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Amongthe 994\u2009789 reports recorded in the database, 136 were Sweet's syndrome, of which 50.7% were men and the median age was 59\u2009years (range 15\u201391). A total of 224 drugs were mentioned as suspects: 21.0% were antibacterials, 19.2% were antineoplastics and 12.1% were immunosuppressants. Median time to onset from drug initiation to the development of Sweet's syndrome was 15\u2009days (range 1\u20131095). The highest RORs were observed with bortezomib (74.04 [40.8\u2013134.2]), azacitidine (72.14 [29.4\u2013176.9]), perfilgrastim (67.05 [21.2\u2013211.6]), azathioprine (55.46 [34.8\u201388.4]) and bendamustine (35.84 [11.4\u2013112.8]).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Pharmacovigilance signals have been observed between the occurrence of Sweet's syndrome and colony\u2010stimulating factors, immunosuppressants, antineoplastics and antibiotics. Clinicians should be aware of the potential associations with these drugs and should be encouraged to report any case of drug\u2010induced Sweet's syndrome.<\/jats:p><\/jats:sec>","DOI":"10.1111\/bcp.15873","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T11:39:26Z","timestamp":1691581166000},"page":"1873-1879","source":"Crossref","is-referenced-by-count":8,"title":["Drug\u2010induced Sweet's syndrome: A case\/non\u2010case study in the French pharmacovigilance database"],"prefix":"10.1111","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5339-5104","authenticated-orcid":false,"given":"Salom\u00e9","family":"Martin","sequence":"first","affiliation":[{"name":"Regional Centre of Pharmacovigilance and Pharmacoepidemiology Reims University Hospital  51100 Reims France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5645-8366","authenticated-orcid":false,"given":"Thierry","family":"Trenque","sequence":"additional","affiliation":[{"name":"Regional Centre of Pharmacovigilance and Pharmacoepidemiology Reims University Hospital  51100 Reims France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Herlem","sequence":"additional","affiliation":[{"name":"Regional Centre of Pharmacovigilance and Pharmacoepidemiology Reims University Hospital  51100 Reims France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charl\u00e8ne","family":"Boulay","sequence":"additional","affiliation":[{"name":"Regional Centre of Pharmacovigilance and Pharmacoepidemiology Rouen University Hospital  76000 Rouen France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Pizzoglio","sequence":"additional","affiliation":[{"name":"Regional Centre of Pharmacovigilance and Pharmacoepidemiology Lyon University Hospital  69495 Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4395-2445","authenticated-orcid":false,"given":"Brahim","family":"Azzouz","sequence":"additional","affiliation":[{"name":"Regional Centre of Pharmacovigilance and Pharmacoepidemiology Reims University Hospital  51100 Reims France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,8,28]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102133.1964.tb14541.x"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750\u20101172\u20102\u201034"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365\u20104362.2003.01891.x"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00414"},{"issue":"3","key":"e_1_2_10_6_1","first-page":"167","article-title":"Diagnostic criteria for Sweet's syndrome","volume":"37","author":"Su WP","year":"1986","journal-title":"Cutis"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190\u20109622(96)90080\u20108"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2015.12.001"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102125.2011.04037.x"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2019.09.004"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2019.01.006"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018\u2010199920020\u201000002"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468\u20103083.2004.00866.x"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.06.023"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1H563"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431\u2010010\u20101201\u2010z"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2020.07.043"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14754"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.2933"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0190\u20109622(95)91382\u20103"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.12.028"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346\u20108138.12081"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12383"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000820"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102141.2005.05636.x"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1383"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12727"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp110523"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14461"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.4099"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0b013e32835ad132"},{"issue":"15","key":"e_1_2_10_32_1","first-page":"588","article-title":"Sweet's syndrome: a study of 16 cases","volume":"109","author":"Ginarte M","year":"1997","journal-title":"Med Clin (Barc)"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102133.1995.tb02686.x"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12759"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000730"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2026834"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.12890\/2021_002484"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346\u20108138.16311"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.13350"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.07.005"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.dad.0000249887.59810.76"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13232"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.3.345"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365\u20102125.1999.00881.x"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.13.1588"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.15873","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T09:54:30Z","timestamp":1722333270000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.15873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,28]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10.1111\/bcp.15873"],"URL":"https:\/\/doi.org\/10.1111\/bcp.15873","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,28]]}}}